MedTrace Logo

Livet Skal Leves (A Life to Live)

NCT03957512 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2019-05-22

No results posted yet for this study

Summary

The overall objective of this project is to optimize the use of diagnostic methods and follow-up programs in infants with congenital heart defects (CHDs) in order to reduce death and complications

Conditions

  • Heart Defects, Congenital

Interventions

PROCEDURE

Heart surgery

All invasive procedures

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Henrik Holmstrøm, Dr Med · Oslo University Hospital/University of Oslo

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03957512 on ClinicalTrials.gov